Japan Liquid Biopsy Market was valued at USD 0.9 Billion in 2022 and is projected to reach USD 2.2 Billion by 2030, growing at a CAGR of 12.1% from 2024 to 2030.
The Japan liquid biopsy market has seen significant growth due to its application in oncology, particularly for cancer diagnostics and monitoring. Liquid biopsy, which involves the analysis of circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) from blood samples, provides a minimally invasive method for detecting and managing various types of cancers. This approach allows for early detection, personalized treatment planning, and monitoring of treatment response, making it a valuable tool in the oncology sector. The non-invasive nature of liquid biopsies also reduces the need for repeated tissue biopsies, which can be more invasive and uncomfortable for patients. The ability to track tumor mutations over time can lead to more effective and tailored therapeutic strategies, thus driving the demand for liquid biopsy applications in cancer care across Japan.
In addition to oncology, liquid biopsy applications extend to prenatal testing and transplantation monitoring. Prenatal testing involves analyzing fetal DNA present in the mother's blood to screen for genetic conditions such as Down syndrome. This non-invasive method provides expectant parents with crucial information about the health of their unborn child without the risks associated with invasive procedures like amniocentesis. Transplantation monitoring, on the other hand, utilizes liquid biopsy to detect signs of organ rejection or graft failure by analyzing donor-derived DNA in the recipient's blood. This application helps in the early detection of potential complications, allowing for timely intervention and better management of transplant patients.
Get an In-Depth Research Analysis of the Japan Liquid Biopsy Market Size And Forecast [2025-2032]
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Liquid Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Liquid Biopsy Market
Reference Laboratory
The Hospital
Research Center
Other
Based on Types the Market is categorized into Below types that held the largest Liquid Biopsy market share In 2023.
Test Suite
Equipment
Service
Japan (United States, Japan and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Liquid Biopsy Market Research Analysis
1. Introduction of the Japan Liquid Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Liquid Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Liquid Biopsy Market, By Type
6. Japan Liquid Biopsy Market, By Application
7. Japan Liquid Biopsy Market, By Geography
Japan
Europe
Asia Pacific
Rest of the World
8. Japan Liquid Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Japan Research and Consulting firm servicing over 5000+ Japan clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/